DB code: T00407
RLCP classification | 6.30.97700.5320 : Double-bonded atom exchange | |
---|---|---|
8.1121121.660330.5528 : Isomerization | ||
5.524.3198500.5541 : Elimination | ||
6.40.521000.5530 : Double-bonded atom exchange | ||
CATH domain | 2.10.25.30 : Laminin | Catalytic domain |
3.40.640.10 : Aspartate Aminotransferase; domain 2 | Catalytic domain | |
3.90.1150.10 : Aspartate Aminotransferase, domain 1 | ||
E.C. | 4.4.1.4 | |
CSA | ||
M-CSA | ||
MACiE |
CATH domain | Related DB codes (homologues) |
---|
Uniprot Enzyme Name | UniprotKB | Protein name | Synonyms | Pfam |
---|---|---|---|
Q01594 |
Alliin lyase 1
|
Alliinase-1
EC 4.4.1.4 Cysteine sulphoxide lyase 1 |
PF04864
(Alliinase_C)
PF04863 (EGF_alliinase) [Graphical View] |
KEGG enzyme name |
---|
Alliin lyase
Alliinase Cysteine sulfoxide lyase Alkylcysteine sulfoxide lyase S-alkylcysteine sulfoxide lyase L-cysteine sulfoxide lyase S-alkyl-L-cysteine sulfoxide lyase Alliin alkyl-sulfenate-lyase |
UniprotKB: Accession Number | Entry name | Activity | Subunit | Subcellular location | Cofactor |
---|---|---|---|---|---|
Q01594 | ALLN1_ALLSA | An S-alkyl-L-cysteine S-oxide = an alkyl sulfenate + 2-aminoacrylate. | Homodimer. | Vacuole. | Pyridoxal phosphate. |
KEGG Pathways | Map code | Pathways | E.C. |
---|
Compound table | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cofactors | Substrates | Products | Intermediates | |||||||||||
KEGG-id | C00018 | C00698 | C03726 | C02245 | C02218 | I00185 | I00071 | I00184 | I00171 | |||||
E.C. | ||||||||||||||
Compound | Pyridoxal phosphate | Cl- | S-alkyl-L-cysteine S-oxide | alkyl sulfenate | 2-aminoacrylate | Geminal-diamine transition-state (active-site Lys-PLP-S-alkyl-L-cysteine S-oxide) | External aldimine intermediate (PLP-S-alkyl-L-cysteine S-oxide) | Quinonoid intermediate (PLP-S-alkyl-cysteine S-oxide) | Aminoacrylate intermediate (PLP-dehydroAla) | |||||
Type | aromatic ring (with nitrogen atoms),phosphate group/phosphate ion | halide | amino acids,sulfoxide group | sulfenic acid | amino acids | |||||||||
ChEBI |
18405 18405 |
17996 17996 |
17123 76565 17123 76565 |
|||||||||||
PubChem |
1051 1051 |
312 312 |
123991 72551549 123991 72551549 |
|||||||||||
1lk9A01 | Unbound | Bound:_CL | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
1lk9B01 | Unbound | Bound:_CL | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2horA01 | Unbound | Bound:_CL | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxA01 | Unbound | Bound:_CL | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxB01 | Unbound | Bound:_CL | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxC01 | Unbound | Bound:_CL | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxD01 | Unbound | Bound:_CL | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
1lk9A02 | Bound:PLP | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
1lk9B02 | Bound:PLP | Unbound | Unbound | Unbound | Unbound | Transition-state-analogue:PLP-DHA-LYS_251 | Unbound | Unbound | Unbound | |||||
2horA02 | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxA02 | Analogue:P1T | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Intermediate-bound:P1T | |||||
2hoxB02 | Analogue:P1T | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Intermediate-bound:P1T | |||||
2hoxC02 | Analogue:P1T | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Intermediate-bound:P1T | |||||
2hoxD02 | Analogue:P1T | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Intermediate-bound:P1T | |||||
1lk9A03 | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
1lk9B03 | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2horA03 | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxA03 | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxB03 | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxC03 | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | |||||
2hoxD03 | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound | Unbound |
Reference for Active-site residues | ||
---|---|---|
resource | references | E.C. |
Literature [3], [4] |
Active-site residues | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
PDB | Catalytic residues | Cofactor-binding residues | Modified residues | Main-chain involved in catalysis | Comment | |||||
1lk9A01 | SER 63;TYR 92 | PHE 94;SER 98;PHE 100 (Chloride binding) | GLY 64 | |||||||
1lk9B01 | SER 63;TYR 92 | PHE 94;SER 98;PHE 100 (Chloride binding) | GLY 64 | |||||||
2horA01 | SER 63;TYR 92 | PHE 94;SER 98;PHE 100 (Chloride binding) | GLY 64 | |||||||
2hoxA01 | SER 63;TYR 92 | PHE 94;SER 98;PHE 100 (Chloride binding) | GLY 64 | |||||||
2hoxB01 | SER 63;TYR 92 | PHE 94;SER 98;PHE 100 (Chloride binding) | GLY 64 | |||||||
2hoxC01 | SER 63;TYR 92 | PHE 94;SER 98;PHE 100 (Chloride binding) | GLY 64 | |||||||
2hoxD01 | SER 63;TYR 92 | PHE 94;SER 98;PHE 100 (Chloride binding) | GLY 64 | |||||||
1lk9A02 | TYR 165;ASP 225;TYR 228;LYS 251 | LYS 251 (PLP binding) | ||||||||
1lk9B02 | TYR 165;ASP 225;TYR 228;LYS 251 | LYS 251 (PLP binding) | ||||||||
2horA02 | TYR 165;ASP 225;TYR 228;LYS 251 | LYS 251 (PLP binding) | ||||||||
2hoxA02 | TYR 165;ASP 225;TYR 228;LYS 251 | LYS 251 (PLP binding) | ||||||||
2hoxB02 | TYR 165;ASP 225;TYR 228;LYS 251 | LYS 251 (PLP binding) | ||||||||
2hoxC02 | TYR 165;ASP 225;TYR 228;LYS 251 | LYS 251 (PLP binding) | ||||||||
2hoxD02 | TYR 165;ASP 225;TYR 228;LYS 251 | LYS 251 (PLP binding) | ||||||||
1lk9A03 | ||||||||||
1lk9B03 | ||||||||||
2horA03 | ||||||||||
2hoxA03 | ||||||||||
2hoxB03 | ||||||||||
2hoxC03 | ||||||||||
2hoxD03 |
References for Catalytic Mechanism | ||
---|---|---|
References | Sections | No. of steps in catalysis |
[1]
|
Scheme 1 | |
[4]
|
Scheme 1 |
References | |
---|---|
[1] | |
Resource | |
Comments | |
Medline ID | |
PubMed ID | 9799098 |
Journal | Eur J Biochem |
Year | 1998 |
Volume | 257 |
Pages | 21-30 |
Authors | Manabe T, Hasumi A, Sugiyama M, Yamazaki M, Saito K |
Title |
Alliinase [S-alk(en)yl-L-cysteine sulfoxide lyase] from Allium tuberosum (Chinese chive)--purification, |
Related PDB | |
Related UniProtKB | |
[2] | |
Resource | |
Comments | |
Medline ID | |
PubMed ID | 9914259 |
Journal | Curr Opin Struct Biol |
Year | 1998 |
Volume | 8 |
Pages | 759-69 |
Authors | Jansonius JN |
Title |
Structure, |
Related PDB | |
Related UniProtKB | |
[3] | |
Resource | |
Comments |
X-RAY CRYSTALLOGRAPHY (1.53 ANGSTROMS) OF 39-465, |
Medline ID | |
PubMed ID | 12235163 |
Journal | J Biol Chem |
Year | 2002 |
Volume | 277 |
Pages | 46402-7 |
Authors | Kuettner EB, Hilgenfeld R, Weiss MS |
Title | The active principle of garlic at atomic resolution. |
Related PDB | 1lk9 |
Related UniProtKB | Q01594 |
[4] | |
Resource | |
Comments |
X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 39-465, |
Medline ID | |
PubMed ID | 17174334 |
Journal | J Mol Biol |
Year | 2007 |
Volume | 366 |
Pages | 611-25 |
Authors | Shimon LJ, Rabinkov A, Shin I, Miron T, Mirelman D, Wilchek M, Frolow F |
Title | Two structures of alliinase from Alliium sativum L.: apo form and ternary complex with aminoacrylate reaction intermediate covalently bound to the PLP cofactor. |
Related PDB | 2hor 2hox |
Related UniProtKB | Q01594 |
Comments |
---|
This enzyme belongs to the class-I of PLP-dependent enzymes superfamily (see [3]).
This enzyme cleaves the beta-carbon-gamma-sulfur bond of sulfoxide derivatives of cysteine to produce allicin, This enzyme catalyzes the following reactions (see [2], (A) Formation of external aldimine (with amine group of S-alkyl-L-cysteine sulfoxide); Exchange of double-bonded atoms (or transaldimination) (B) Isomerization (shift of double-bond position) forming a quinonoid intermediate (I00184) (C) Eliminative double-bond formation (C-S lysis from the intermediate) leading to formation of an aminoacrylate-PLP intermediate (I00171) and a product, (D) Formation of internal aldimine of PLP with active-site Lys, These reactions proceed in the following way (see [3], (A) Formation of external aldimine (with amine group of S-alkyl-L-cysteine sulfoxide); Exchange of double-bonded atoms (or transaldimination) (A1) Tyr228 interacts with O3' atom of PLP, (A2) The amine group of the substrate makes a nucleophilic attak on the C4' of the internal aldimine, (A3) Proton transfer from the substrate-derived amine group to epsilon-nitrogen atom of Lys251 must occur. (A4) The lone pair of the amine group of the substrate makes a nucleophilic attack on the C4' atom to form a double-bond, (B) Isomerization (shift of double-bond position) forming a quinonoid intermediate (I00184) (B0) Asp225 interacts with the N1 atom of PLP, (B1) The protonated sidechain of Lys251 must be activated. (B2) The activated Lys251 acts as a general base to deprotonate alpha-carbon of the external aldimine intermediate (I00071), (C) Eliminative double-bond formation (C-S lysis from the intermediate) leading to formation of an aminoacrylate-PLP intermediate (I00171) and a product, (C0) Asp225 interacts with the N1 atom of PLP, (C1) The protonated Lys251 may act as a general acid to protonate the eliminated sulfoxide group, (D) Formation of internal aldimine of PLP with active-site Lys, ## This reaction is the reverse reaction of reaction (A). (D1) Tyr228 interacts with O3' atom of PLP, (D2) The amine group of the Lys251 makes a nucleophilic attak on the C4' of the external aldimine, (D3) Proton transfer from the epsilon-nitrogen atom of Lys251 to the amine group of the leaving group must occur. (D4) The lone pair of the amine group of Lys251 makes a nucleophilic attack on the C4' atom to form a double-bond, |
Created | Updated |
---|---|
2010-08-05 | 2015-07-29 |